U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
PANITUMUMAB
6A901E312A
US Approved Rx (2006)
First approved in 2006
General
Record Details
Names
15
Classification
8
Identifiers
17
Subunits
4
Relationships
1
Active Moiety
1
Characteristic Attributes
3
PANITUMUMAB
6A901E312A
US Approved Rx (2006)
First approved in 2006
General
Approval Year
2006
178
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG2
Sequence Origin
HUMAN
Sequence Type
COMPLETE
Record UNII
6A901E312A
Record Status
Validated (UNII)
Record Version
28
27
26
25
24
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
15
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
PANITUMUMAB
Official Name
English
PANITUMUMAB [PURPLE BOOK CDER]
Common Name
English
panitumumab [INN]
Common Name
English
PANITUMUMAB [MART.]
Common Name
English
PANITUMUMAB [VANDF]
Common Name
English
Showing 1 to 5 of 15 entries
Previous
1
2
3
Next
Classification
8
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Solid tumors
LiverTox
Antineoplastic
Solid tumors
TK receptor inhiibitor, EGRF
[mAb]
LIVERTOX
NBK548182
INTESTINAL NEOPLASMS
EMA EPAR
DISEASES
DIGESTIVE SYSTEM DISEASES
GASTROINTESTINAL DISEASES
INTESTINAL DISEASES
INTESTINAL NEOPLASMS
COLORECTAL NEOPLASMS
EMA ASSESSMENT REPORTS
VECTIBIX (AUTHORIZED: COLORECTAL NEOPLASMS)
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Antineoplastic Agent
Pharmacologic Substance
[C1909]
Antineoplastic Agent
[C274]
Angiogenesis Inhibitor
NCI_THESAURUS
C1742
Monoclonal Antibody
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
[C20401]
Anti-EGFR Monoclonal Antibody
NCI_THESAURUS
C133878
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Identifiers
17
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
RXCUI
263034
PRIMARY
RxNorm
USAN
PP-83
PRIMARY
IUPHAR
6883
PRIMARY
MERCK INDEX
m8382
PRIMARY
Merck Index
INN
8499
PRIMARY
Showing 1 to 5 of 17 entries
Previous
1
2
3
4
Next
Subunits
4
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
RO03J093CP
EPIDERMAL GROWTH FACTOR RECEPTOR
TARGET -> INHIBITOR
Interaction Type:
COMPETITIVE INHIBITOR
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
6A901E312A
PANITUMUMAB
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
3
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Biological Half-life
PHARMACOKINETIC
7.5 days (average)
Molecular Formula
CHEMICAL
ESTIMATED
C6398H9862N1694O2016S48
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 144000 Da (average)
